CID 71621331

Futibatinib

Structural Information

Molecular Formula
C22H22N6O3
SMILES
COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)[C@H]4CCN(C4)C(=O)C=C)OC
InChI
InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1
InChIKey
KEIPNCCJPRMIAX-HNNXBMFYSA-N
Compound name
1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

43
References

1099
Patents

418.17532 Da
Monoisotopic Mass

2.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 419.18260 200.9
[M+Na]+ 441.16454 212.7
[M+NH4]+ 436.20914 201.5
[M+K]+ 457.13848 207.2
[M-H]- 417.16804 194.8
[M+Na-2H]- 439.14999 201.9
[M]+ 418.17477 199.8
[M]- 418.17587 199.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe